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结果：1.未附加 anti-CD70处理组，皮肤移植一个月后 CD4+ Tm/CD4+ T比
例为 47.32±4.28%，CD8+ Tm/CD8+ T比例为 23.18±2.77%，附加 anti-CD70处理
组两者比例分别降低为 34.10±2.71%、12.19±3.52%（两组间 Tm值比较具有统计
学差异，P<0.05）。2.未附加 anti-CD70 处理组心脏移植后移植物的平均生存期
(Mean survival time, MST)为 10天（day, d），附加 anti-CD70处理组心脏移植后移
植物 MST>90d（两组比较，P<0.001）。 3.和未附加 anti-CD70 处理组相比，附
加 anti-CD70处理组受者脾脏同种反应性 T细胞增殖能力显著降低，移植物中浸
润的 CD8+ T 细胞减少到 23.39±2.78%（P<0.01），同时，调节性 T细胞（regulatory 




































Background： Transplant patients may develop alloreactive memory T cells 
after exposure to alloantigens during previous transplantations, blood transfusions, 
pregnancies, or due to continuous exposure to bacterial and viral pathogens. In adult 
humans, 40–50% of T cells circulating in the peripheral blood have memory 
phenotypes. Memory T cells play a key role in accelerated rejection. Furthermore, 
there is a growing body of evidence that B-cell production of alloantibodies is also an 
important element in the accelerated rejection. Therefore, inhibiting the generation of 
memory T cells and alloantibodies during the primary transplantation is a critical step 
in the prevention of rejection. In this study, we attempted to reduce the generation of 
memory T cells and alloantibodies by treating mice with anti-CD70 added in 
combination with an anti-CD154/LFA-1 regimen during primary transplantation. We 
assumed that this approach could alleviate the accelerated rejection mediated by 
memory T cells during secondary heart transplantation, and we explored the possible 
mechanism of the obviously prolonged survival.  
Methods： C57BL/6 mice that had rejected BALB/c skin grafts 4 weeks earlier 
were used as recipients. The recipient mice were treated with anti-CD154/LFA-1 with 
or without anti-CD70 during the primary skin transplantation and anti-CD154/LFA-1 
or not during the secondary transplantation of BALB/c heart. We evaluated the impact 
of combinations of antibody-mediated blockade on the generation of memory T cells 
and allograft survival.  
Results：1. One month after the primary skin transplantation, the proportions of 
CD4+ memory T cells/CD4+ T cells and CD8+memory T cells/CD8+ T cells in the 
anti-CD154/LFA-1 combination group were 47.32±4.28% and 23.18±2.77%, 
respectively. In the group that included anti-CD70 treatment, the proportions were 
reduced to 34.10±2.71% and 12.19±3.52% (P<0.05 when comparing the proportion of 















treatment regimen prolonged the mean survival time following secondary heart 
transplantation from 10 days to more than 90 days (P<0.001). 3. Compared to the 
group without anti-CD70 treatment, the group addition anti-CD70 showed lower 
allogenic proliferation of recipient splenic T cells, and decreased graft-infiltrating 
lymphocytes to 23.39±2.78%（P<0.01）. Meanwhile, the proportion of regulatory T 
cells were increased to 9.46±1.48% on day 100 post-transplantation(P<0.05).  
Conclusions. The addition of anti-CD70 to the anti-CD154/LFA-1 combination 
given during the primary transplantation reduced the generation of memory T cells. 
This therapy regimen provided a potential means to alleviate the accelerated rejection 
mediated by memory T cells during secondary heart transplantation and markedly 
prolong the survival of heart allografts.  
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原微生物[1,2]等多种原因，外周血中有 40~50%的 T 细胞有记忆性的表型，对移
植物初次及再次移植的存活时间造成重大影响[3,4]。随着临床移植的开展和动物














































1.1.1.2 急性排斥反应（acute rejection，AR） 
急性排斥反应是临床器官移植排斥反应中最常见的类型，多发生在移植术后
1周以后，绝大多数发生在术后 6个月之内。病理学表现为移植物内大量的 T淋






























T 细胞是 T 淋巴细胞的简称，来源于骨髓样干细胞，在胸腺中发育成熟。T
细胞具有高度异质性，根据其表面标志和功能特征可分为若干种类。根据所处的
活化阶段，T细胞可分为初始、效应性和记忆性 T细胞；根据表达 T细胞受体（T 
cell receptor, TCR）的类型，T细胞可分为 αβ+、γδ+ T细胞；根据是否表达 CD4
或者 CD8分子，T细胞可分为 CD4+、CD8+ T细胞；根据免疫功能，T细胞可分
为辅助性 T细胞（help T cell, Th）、细胞毒性 T细胞（cytotoxic T lymphocytes , Tc
或 CTL）和调节性 T细胞（regulatory T cells, Tregs）。 
1.1.2.1 初始、效应性和记忆 T细胞 
1. 初始 T细胞 
初始 T细胞(naïve T cell)或称 Th0细胞是从未经过抗原刺激的成熟 T细胞，
经历了胸腺中的阳性和阴性选择[9]。初始 T细胞虽然已经成熟，但明显不同于激
活的 T细胞。初始 T细胞通常表面高表达 L-选择素（CD62L），缺乏表达激活标
志（CD25、CD44或 CD69）或记忆标志（例如 CD45亚型）。在初始状态时，T
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初始 T细胞在外周淋巴器官内接受抗原刺激而活化，分化为效应或记忆 T细
胞。效应 T 细胞存活期较短，除表达高水平、高亲和力 IL-2 受体外，还表达粘
附分子（整合素和 CD44）和 CD45RO。效应 T细胞与初始 T细胞不同，不参与
淋巴细胞再循环，而是向外周炎症组织迁移。 
3. 记忆性 T细胞 
记忆性 T细胞是一类抗原特异性 T细胞，在感染结束后长期存在。再次接触
相同抗原后它们能够快速扩增并形成大量的效应 T细胞，使免疫系统对过去感染
抗原具有记忆性。记忆 T细胞包括 2个亚类：中枢记忆 T细胞（central memory T 
cells, TCM）和效应记忆 T细胞（effector memory T cells, TEM）。记忆 T细胞可以
是 CD4+ Tm或 CD8+ Tm，这些 Tm不是静止的，它们有规律地进行自发增殖来补
充其数量，使其维持在一定水平。 
1.1.2.2 Th、Tc和 Tregs细胞 
1. Th细胞 
Th 细胞在免疫应答过程中对其他白细胞提供辅助性作用，包括促进 B 细胞
成熟并分化为浆细胞、激活 Tc 细胞和巨噬细胞等多项功能。这些细胞也被认为
是 CD4+ T细胞，由于其表面表达 CD4。Th细胞可被抗原提呈细胞(anti-presenting 
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